Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Pharmacopoeia 2010 Edition To Raise Standards

This article was originally published in PharmAsia News

Executive Summary

Chinese Pharmacopoeia, the gold standard for medicine in China, has begun revising its contents. The 2010 edition will extend the record of chemical pharmaceuticals and TCM, adjust the standards of pharmaceutical technology and prepare a catalog of newly added drugs. The revised draft will be completed before the end of 2008. The pharmaceutical industry subscribes to the standards in Chinese Pharmacopoeia as the minimum basis for the quality of all drugs and production technology. With the Chinese authority's stricter supervision of adverse drug reactions, the revision is set to raise the standards for drug quality. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067793

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel